Close Menu

Two Blades Foundation

The partners will investigate new sources of potato infections, including late blight and test new genes for their ability to confer disease resistance.

The money will be distributed to research groups studying the mechanisms by which three major agricultural plant systems resist infection by pathogens.

The arrangement covers Cellectis' TALEN technology and Two Blades' TAL effector code technology.

NEW YORK (GenomeWeb News) – DuPont Pioneer and the Two Blades Foundation today announced a research collaboration to develop soybean varieties with greater resistance to Asian Soybean Rust.

NEW YORK (GenomeWeb News) – The Two Blades Foundation today announced a licensing agreement with Dupont Pioneer providing it access to 2Blades' TAL Code technology for commercial use in certain crop plants.

NEW YORK (GenomeWeb News) – The Two Blades Foundation and Monsanto today announced an expansion of their agreement to provide Monsanto additional TAL Code technologies.

NEW YORK (GenomeWeb News) – The Two Blades Foundation today said it has completed a non-exclusive licensing agreement with KWS SAAT covering Two Blades' Transcription Activator Like effector code technology for genome engineering in certain crops.

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific this week said that it has acquired Doe & Ingalls Management, a provider of production chemicals and customized supply chain services to the life sciences and microelectonic industries, for approximately $175 million in cash.

NEW YORK (GenomeWeb News) – The Two Blades Foundation said on Monday that it has licensed the TAL Code technology to Monsanto on a non-exclusive basis.

NEW YORK (GenomeWeb News) – The Two Blades Foundation has granted Syngenta access to its genome engineering technology for commercial uses in certain crop plants under an agreement announced late on Tuesday.

Pages

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.